AGIOS director exercises 1,976 RSUs into shares
AGIOS PHARMACEUTICALS director Catherine Owen Adams exercised restricted stock units into common stock.
Rhea-AI Filing Summary
AGIOS PHARMACEUTICALS director Catherine Owen Adams exercised restricted stock units into common stock. She converted 1,976 restricted stock units into 1,976 shares of common stock at a stated price of $0.00 per share and did not sell any shares. Following the transaction, she directly holds 8,049 shares of common stock. The restricted stock units were granted on June 13, 2023 and vest in three equal annual installments beginning on June 13, 2024, with vested shares delivered within three business days after vesting.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted stock units | 1,976 | $0.00 | $0.00 |
| Exercise | Common stock | 1,976 | $0.00 | $0.00 |
Footnotes (2)
- F1. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
- F2. The restricted stock units were granted on June 13, 2023. Beginning on June 13, 2024, the shares underlying the stock units will vest in three equal annual installments. Vested shares will be delivered to the reporting person within three business days after such shares become vested.
Key Figures
Key Terms
restricted stock units financial
derivative security financial
vest financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did AGIOS (AGIO) report for Catherine Owen Adams?
What happened to the restricted stock units in the AGIOS (AGIO) Form 4?
When were Catherine Owen Adams’ AGIOS (AGIO) restricted stock units granted and how do they vest?
Did the AGIOS (AGIO) Form 4 disclose any stock sales by Catherine Owen Adams?
AI-generated analysis. How Rhea-AI works. Not financial advice.